GNOM SEC Filings — Global X Genomics & Biotechnology ETF
Data updated: 2026-07-29
44 SEC filings are listed: 10 prospectuses (latest Mar 27, 2026), 27 quarterly N-PORT holdings reports (latest Jul 29, 2026) and 7 annual N-CEN reports (latest Feb 12, 2026).
GNOM Prospectus (485BPOS / 497)
Objective, strategy, fees and risks. 10 filings on SEC EDGAR.
GNOM Portfolio holdings (N-PORT)
Full holdings and monthly flows, filed quarterly. 27 filings on SEC EDGAR.
- Filed Jul 29, 2026
- Filed Apr 29, 2026
- Filed Jan 29, 2026
- Filed Oct 30, 2025
- Filed Jul 30, 2025
- Filed Apr 29, 2025
- Filed Jan 28, 2025
- Filed Oct 30, 2024
- Filed Jul 30, 2024
- Filed Apr 29, 2024
- Filed Jan 29, 2024
- Filed Oct 30, 2023
- Filed Jul 26, 2023
- Filed May 1, 2023
- Filed Jan 27, 2023
- Filed Oct 27, 2022
- Filed Jul 29, 2022
- Filed Apr 28, 2022
- Filed Jan 27, 2022
- Filed Oct 28, 2021
- Filed Jul 28, 2021
- Filed Apr 28, 2021
- Filed Jan 27, 2021
- Filed Oct 28, 2020
- Filed Jul 27, 2020
- Filed Apr 28, 2020
- Filed Jan 23, 2020
GNOM Annual census (N-CEN)
Service providers, brokerage and operations. 7 filings on SEC EDGAR.
Browse every Global X Genomics & Biotechnology ETF filing on SEC EDGAR
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, and annual data from Form N-CEN.
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.